Global Neurovascular Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The global neurovascular devices market has been segmented by Device Type, Applications, Disease Pathology and Geography. In terms of device type, the market is primarily divided into stents, catheters, embolic agents, coils, and other devices. Stents are used to support and reinforce blood vessels during procedures such as stent-assisted coiling or flow diversion for conditions like cerebral aneurysms and carotid artery stenosis. Catheters, often used in conjunction with stents or embolic agents, are essential for delivering these devices to the affected area of the brain. Embolic agents are used to block abnormal blood vessels, especially in the treatment of arteriovenous malformations (AVMs) and fistulas, while neurovascular coils are employed to occlude aneurysms or malformed blood vessels. These devices are increasingly sophisticated, minimally invasive, and designed to provide better outcomes, thereby driving the growth of this segment in the neurovascular devices market.

In terms of applications, the market is driven by procedures related to stroke management, aneurysm treatment, and vascular occlusion. For stroke management, devices such as thrombectomy systems, aspiration systems, and stent retrievers are used to remove blood clots from the brain in the case of ischemic strokes, improving patient outcomes by restoring blood flow. Aneurysm treatment involves the use of devices like intracranial stents, coiling devices, and flow diversion devices to prevent rupture and manage cerebral aneurysms. Vascular occlusion devices are employed in procedures to treat arteriovenous malformations (AVMs) and fistulas, where abnormal blood vessels need to be closed or blocked. The increasing adoption of minimally invasive techniques and technological advancements are driving the growth of neurovascular device applications in these areas, offering patients more effective treatment options with reduced recovery times.

The disease pathology segment further highlights the diverse applications of neurovascular devices, as it is segmented into ischemic strokes, cerebral aneurysms, carotid artery stenosis, arteriovenous malformations (AVMs), fistulas, and others. Each pathology requires specialized devices designed for optimal treatment. Ischemic strokes are treated with thrombectomy and clot retrieval systems, while cerebral aneurysms are managed with stent-assisted coiling or flow diversion stents. Carotid artery stenosis is treated with carotid artery stents to prevent stroke risk, and AVMs and fistulas are treated with embolization devices. The demand for these devices is increasing due to the rising prevalence of neurological disorders and the need for more advanced, minimally invasive solutions. Geographically, North America is the largest market for neurovascular devices, driven by the high adoption of advanced medical technologies, a strong healthcare infrastructure, and significant healthcare expenditure. Europe follows closely, with growing demand for neurovascular procedures, while the Asia-Pacific region is anticipated to experience the highest growth rate due to improving healthcare access, increasing awareness of neurological diseases, and a rising elderly population.

Global Neurovascular Devices Segment Analysis

In this report, the Global Neurovascular Devices Market has been segmented by Device Type, Applications, Disease Pathology and Geography.

Global Neurovascular Devices Market, Segmentation by Device Type

The Global Neurovascular Devices Market has been segmented by Device Type into Cerebral Embolization and Aneurysm Coiling Devices - Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents, Cerebral Angioplasty and Stenting Systems - Carotid Artery Stents and Embolic Protection Systems, Neurothrombectomy Devices - Clot Retrieval Devices, Suction Devices and Vascular Snares, Support Devices - Micro Catheters, and Micro Guidewires.

Cerebral embolization and aneurysm coiling devices represent a critical aspect of neurovascular intervention. These devices are designed to treat cerebral aneurysms by occluding the abnormal blood vessel using coils or other embolic agents. They are minimally invasive and offer a safer alternative to traditional surgical methods, thereby gaining popularity among both patients and healthcare providers.

Cerebral angioplasty and stenting systems play a crucial role in treating stenosis or narrowing of blood vessels in the brain. These devices help restore blood flow by expanding the narrowed arteries and providing structural support through stents. With a growing incidence of ischemic strokes and other cerebrovascular diseases, the demand for these systems is expected to rise significantly in the coming years. Neurothrombectomy devices are another important category in the neurovascular market, particularly in the treatment of acute ischemic stroke. These devices are used to remove blood clots from cerebral arteries, restoring blood flow and preventing further brain damage. As stroke continues to be a leading cause of disability and mortality worldwide, the adoption of neurothrombectomy devices is anticipated to increase, supported by technological advancements and clinical evidence.

Support devices encompass a range of products aimed at facilitating neurovascular procedures and improving patient outcomes. This category includes microcatheters, guidewires, and access devices, among others, which are essential for navigating the complex vascular anatomy of the brain and delivering therapeutic agents precisely. As the field of neurointervention evolves, the demand for innovative support devices that enhance procedural efficiency and safety is expected to grow, driving market expansion.

Global Neurovascular Devices Market, Segmentation by Applications

The Global Neurovascular Devices Market has been segmented by Applications into Stroke, Cerebral Artery Stenosis, Cerebral Aneurysm and Others.

One of the primary applications driving this market is stroke management. Stroke is a leading cause of disability and mortality worldwide, and neurovascular devices play a crucial role in both the acute treatment and long-term management of stroke patients. These devices include clot retrieval devices, stent retrievers, and other tools used in thrombectomy procedures to remove blood clots from blocked vessels, restoring blood flow to the brain and minimizing neurological damage.

Cerebral artery stenosis, or the narrowing of arteries in the brain, is another key application area for neurovascular devices. Stenosis can lead to reduced blood flow to the brain, increasing the risk of stroke and other neurological complications. Neurovascular devices used in the management of cerebral artery stenosis include stents and angioplasty balloons, which are used to widen narrowed arteries and improve blood flow.

Cerebral aneurysms, abnormal bulges or ballooning in the walls of brain arteries, represent another significant application segment for neurovascular devices. Aneurysms pose a risk of rupture, which can lead to life-threatening bleeding in the brain. Neurovascular devices such as coils, flow diverters, and stents are used in the treatment of cerebral aneurysms to prevent rupture and reduce the risk of complications. These devices are often deployed via minimally invasive procedures such as endovascular coiling or stent-assisted coiling. Neurovascular devices find applications in various other neurological conditions and procedures. These may include arteriovenous malformations (AVMs), intracranial atherosclerosis, and vasospasm management, among others. The ongoing innovation in neurovascular technologies, coupled with increasing awareness about neurological disorders and advancements in minimally invasive treatment approaches, is expected to drive further growth in the global neurovascular devices market across all application segments.

Global Neurovascular Devices Market, Segmentation by Disease Pathology

The Global Neurovascular Devices Market has been segmented by Disease Pathology into Ischemic Strokes, Cerebral Aneurysm, Carotid Artery Stenosis, Arteriovenous Malformations, Fistulas and Others.

The global neurovascular devices market is segmented by disease pathology into ischemic strokes, cerebral aneurysm, carotid artery stenosis, arteriovenous malformations, fistulas, and others. Ischemic strokes are one of the leading causes of disability worldwide and are caused by blockages in blood vessels that supply blood to the brain. Neurovascular devices, such as stent retrievers, mechanical thrombectomy devices, and aspiration systems, are critical in the treatment of ischemic strokes by helping to remove the blood clot and restore blood flow to the brain. The increasing prevalence of ischemic strokes, along with the rising awareness of timely intervention, is contributing to the growth of this segment, particularly with the advancement of minimally invasive techniques.

Cerebral aneurysms represent another significant pathology in the neurovascular devices market. A cerebral aneurysm is a bulge or ballooning in a blood vessel in the brain, which can lead to life-threatening complications if ruptured. Devices used to treat cerebral aneurysms include intracranial stents, coiling devices, and flow diversion stents. These devices are employed to either reinforce the vessel wall or divert blood flow away from the aneurysm to prevent rupture. With the increasing prevalence of cerebral aneurysms and advancements in device technology, this segment is experiencing rapid growth, driven by the demand for effective, minimally invasive treatment options that can reduce the risks associated with aneurysm rupture.

Carotid artery stenosis and arteriovenous malformations (AVMs) are other key pathologies in the neurovascular devices market. Carotid artery stenosis is the narrowing of the carotid arteries, which can lead to stroke if untreated. Devices like carotid artery stents and stent-grafts are used to open the narrowed arteries and restore normal blood flow to the brain. Similarly, arteriovenous malformations (AVMs), where abnormal connections between arteries and veins occur, can lead to bleeding and neurological impairment. Treatment of AVMs often involves embolization devices and neurovascular coils to block abnormal blood flow and prevent rupture. Fistulas, another pathology in this market, are abnormal connections between blood vessels that can lead to various complications. Neurovascular devices for treating fistulas include embolic agents and coiling devices. Together, these disease pathologies highlight the broad applications of neurovascular devices in treating life-threatening conditions of the brain and central nervous system.

Global Neurovascular Devices Market, Segmentation by Geography

In this report, the Global Neurovascular Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Neurovascular Devices Market Share (%), by Geographical Region, 2024

North America holds a prominent share in the global neurovascular devices market, owing to factors such as the presence of well-established healthcare infrastructure, high healthcare expenditure, and a large patient pool suffering from neurovascular disorders. Additionally, the region boasts extensive research and development activities, leading to the introduction of innovative neurovascular devices.

Europe follows North America closely in market share, fueled by the rising geriatric population prone to neurovascular diseases and the presence of key market players in the region. Countries like Germany, France, and the UK are witnessing significant growth in the neurovascular devices market due to the increasing adoption of minimally invasive procedures and favorable reimbursement policies.

The Asia Pacific region is emerging as a lucrative market for neurovascular devices, attributed to rapid urbanization, improving healthcare infrastructure, and a growing awareness regarding neurovascular diseases. Countries like China, Japan, and India are witnessing substantial investments in healthcare, driving market growth. The Middle East and Africa, along with Latin America, are also witnessing a rise in demand for neurovascular devices, albeit at a slower pace compared to other regions. Factors such as improving healthcare facilities, rising disposable incomes, and increasing awareness about advanced treatment options are contributing to market growth in these regions.

This report provides an in depth analysis of various factors that impact the dynamics of Global Neurovascular Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Aging population
• Technological advancements
• Increasing prevalence of neurological disorders

• Growing demand for minimally invasive procedures: The global neurovascular devices market has been witnessing significant growth, driven largely by the increasing demand for minimally invasive procedures. Minimally invasive techniques offer several advantages over traditional open surgeries, including reduced risk of complications, shorter hospital stays, quicker recovery times, and minimal scarring. These benefits have fueled the adoption of neurovascular devices in the treatment of various neurological disorders, such as aneurysms, arteriovenous malformations (AVMs), and ischemic and hemorrhagic strokes.

  Technological advancements in neurovascular devices have further propelled market growth. Innovations such as stent retrievers, flow diverters, and embolic coils have improved treatment outcomes and expanded the scope of minimally invasive procedures for neurovascular conditions. These devices enable neurosurgeons and interventional radiologists to precisely navigate and treat complex vascular lesions within the brain and spinal cord, leading to better patient outcomes and enhanced quality of life.

  The rising prevalence of neurological disorders, coupled with an aging population, has contributed to the increasing demand for neurovascular devices globally. According to the World Health Organization (WHO), neurological disorders affect millions of people worldwide, leading to a significant burden on healthcare systems. As a result, there is a growing emphasis on early detection and intervention, driving the adoption of neurovascular devices for both diagnostic and therapeutic purposes. With ongoing research and development efforts focused on improving device efficacy and safety profiles, the neurovascular devices market is poised for continued growth in the coming years.

Restraints

• Stringent regulatory requirements
• High cost of neurovascular devices
• Limited access to healthcare facilities

• Risk of complications and adverse events: The global neurovascular devices market has witnessed significant growth in recent years, driven by an increasing prevalence of neurological disorders such as ischemic strokes, aneurysms, arteriovenous malformations, and others. These devices, ranging from stents and embolic coils to flow diverters and neurothrombectomy devices, play a crucial role in the treatment and management of such conditions. However, despite their efficacy, neurovascular interventions carry inherent risks of complications and adverse events.

  One significant risk associated with neurovascular devices is the potential for procedural complications during the intervention itself. These procedures often involve navigating delicate blood vessels within the brain, which can lead to complications such as vessel perforation, thrombosis, or embolism. Moreover, the use of certain devices, such as stents or flow diverters, may inadvertently disrupt the normal blood flow, leading to ischemic events or hemorrhages. The complexity of neurovascular anatomy and variability among patients further compound these risks.

  Post-procedural complications and adverse events pose ongoing challenges in neurovascular interventions. Patients undergoing these procedures may experience complications such as hemorrhage, infection, or neurological deficits following treatment. Additionally, the long-term efficacy and safety of neurovascular devices are subject to scrutiny, with concerns about device migration, thrombosis, or restenosis over time. As such, clinicians must carefully weigh the benefits against the potential risks when selecting and deploying neurovascular devices, ensuring that patients receive optimal care while minimizing the likelihood of adverse outcomes.

Opportunities

• Emerging markets in Asia-Pacific
• Development of innovative neurovascular technologies
• Expansion of product portfolios

• Rising healthcare expenditure globally: The global neurovascular devices market has witnessed significant growth in recent years, driven primarily by the rising healthcare expenditure worldwide. As healthcare budgets increase across various regions, there's a greater focus on advanced medical technologies and treatments, including those for neurovascular conditions. This heightened investment enables healthcare providers to adopt cutting-edge neurovascular devices that enhance diagnostic accuracy, improve treatment outcomes, and reduce patient recovery times. Additionally, the escalating prevalence of neurological disorders such as strokes, aneurysms, and arteriovenous malformations (AVMs) further fuels the demand for innovative neurovascular devices.

  The growing awareness about neurological conditions and advancements in medical research have led to a surge in demand for neurovascular interventions. With increased funding for research and development activities, medical device companies are continually innovating to develop more effective and minimally invasive neurovascular devices. These devices range from clot retrieval systems and embolization coils to stent retrievers and flow diverters, offering healthcare professionals a diverse array of tools to address complex neurovascular disorders. Consequently, as healthcare expenditure continues to rise globally, the neurovascular devices market is poised for sustained growth, driven by technological advancements and expanding applications in neurology.

  The aging population demographic worldwide contributes significantly to the increasing healthcare expenditure and subsequently to the neurovascular devices market growth. Elderly individuals are more susceptible to neurovascular disorders such as ischemic strokes and cerebral aneurysms due to age-related vascular changes and other comorbidities. As governments and healthcare systems allocate more resources to address the healthcare needs of aging populations, there's a greater emphasis on investing in advanced medical technologies, including neurovascular devices. This demographic trend, coupled with rising healthcare expenditure, presents lucrative opportunities for market players to develop innovative neurovascular solutions and expand their global footprint to meet the growing demand for neurological care.

Key players in Global Neurovascular Devices Market include:

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson
• Penumbra Inc
• Terumo Corporation
• MicroPort Scientific Corporation
• Integer Holdings Corporation
• Penumbra Inc
• Balt Extrusion
• Medikit Co Ltd

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis